Palantir sees growth with a Rule of 40 score of 83 and raised guidance by $150M. Read more on why I think it's more of a Hold ...

U.S. Representative Jimmy Gomez, along with members of the California Congressional Delegation and immigration advocates held ...

(Reference: Fang W, Li X, Wang Q, et al. Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutant advanced ...

Global spirit makers are staring down a sobering cocktail of challenges as tariffs and brand boycotts threaten to exacerbate ...

Mia Scott hit a grand slam, Teagan Kavan claimed another win and Texas defeated Texas Tech 10-4 in Game 3 of the Women’s ...

Tesla has spent much of the year dealing with struggling sales and a deteriorating brand. Now CEO Elon Musk has drawn the ire ...

There are eight horses in contention for the 2025 Belmont Stakes title, including the winners from this year's first two ...

With more clinics closing, patients face growing barriers to basic services like checkups, screenings, and birth control.

Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL ...

Final analysis of KEYNOTE-A18 showed that pembrolizumab plus concurrent chemoradiation showed sustained PFS/OS benefits in ...

New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...

At the ASMS 2025 conference, Sciex showcased its latest mass spectrometry system, the ZenoTOF 8600, along with updates to its ...